Macrophage migration inhibitory factor induces MMP-9 expression: Implications for destabilization of human atherosclerotic plaques

Atherosclerosis

Volumn 178, Issue 1, 2005, Pages 207-215

  Kong, Yao Zhong ^a,b   Yu, Xiyong ^b   Tang, Jia Ju ^a   Ouyang, Xiaosen ^b   Huang, Xiao Ru ^b   Fingerle Rowson, Gunter ^c   Bacher, Michael ^d   Scher, Larry A ^e   Bucala, Richard ^f   Lan, Hui Y ^b  

^a The First People's Foshan Hospital   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e Manhasset NY USA   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Macrophages; MIF; MMP 9; Plaque instability; VSMCs

Indexed keywords

GELATINASE B; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; CELLS, CULTURED; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RECOMBINANT PROTEINS; UP-REGULATION;

EID: 10044226344     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.08.030     Document Type: Article

References (38)

1. P. Libby Inflammation in atherosclerosis Nature 420 6917 2002 868 874
2. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
3. M.L. Gronholdt, S. Dalager-Pedersen, and E. Falk Coronary atherosclerosis: determinants of plaque rupture Eur Heart J Suppl C 1998 24 29
4. P.K. Shah Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion Prog Cardiovasc Dis 44 2002 357 368
5. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherosclerosis: the good, the bad, and the ugly Circ Res 90 2002 251 262
6. I.M. Loftus, A.R. Naylor, P.R. Bell, and M.M. Thompson Matrix metalloproteinases and atherosclerotic plaque instability Br J Surg 89 2002 680 694
7. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
8. I.M. Loftus, A.R. Naylor, and S. Goodall Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption Stroke 31 2000 40 47
9. G.K. Sukhova, U. Schonbeck, and E. Rabkin Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable atheromatous plaques Circulation 99 1999 2503 2509
10. H. Uzui, A. Harpf, and M. Liu Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines Circulation 106 2002 3024 3030
11. Z.S. Galis, M. Muszynski, G.K. Sukhova, E. Simon-Morrissey, and P. Libby Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions Ann N Y Acad Sci 748 1995 501 507
12. R. Pyo, J.K. Lee, and J.M. Shipley Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 2000 1641 1649
13. Z.S. Galis, C. Johnson, and D. Godin Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling Circ Res 91 2002 852 859
14. T.B. Rajavashisth, J.K. Liao, and Z.S. Galis Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase J Biol Chem 274 1999 11924 111199
15. X.P. Xu, S.R. Meisel, and J.M. Ong Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages Circulation 99 1999 993 998
16. J. Bernhagen, T. Calandra, and R.A. Mitchell MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Nature. 365 1993 756 759
17. T. Calandra, B. Echtenacher, and D.L. Roy Protection from septic shock by neutralization of macrophage migration inhibitory factor Nat Med 6 2000 164 170
18. A. Mikulowska, C.N. Metz, R. Bucala, and R. Holmdahl Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice J Immunol 158 1997 5514 5517
19. S.C. Donnelly, C. Haslett, and P.T. Reid Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome Nat Med 3 1997 320 323
20. H.Y. Lan, M. Bacher, and N. Yang The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat J Exp Med 185 1997 1455 1465
21. H.Y. Lan, N. Yang, and C. Metz TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis Mol Med 3 1997 136 144
22. H.Y. Lan, N. Yang, and F.G. Brown Macrophage migration inhibitory factor expression in human renal allograft rejection Transplantation 66 1998 1465 1471
23. S.G. Lin, X.Y. Yu, and Y.X. Chen De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits Circ Res 87 2000 1202 1208
24. A. Burger-Kentischer, H. Goebel, and R. Seiler Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis Circulation 105 2002 1561 1566
25. Z. Chen, M. Sakuma, and A.C. Zago Evidence for a Role of Macrophage Migration Inhibitory Factor in Vascular Disease Arterioscler Thromb Vasc Bio 24 2004 1 8
26. A. Schober, J. Bernhagen, and M. Thiele Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice Circulation 109 2004 380 385
27. S. Onodera, K. Kaneda, Y. Mizue, Y. Koyama, M. Fujinaga, and J. Nishihira Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis J Biol Chem 275 2000 444 450
28. S. Onodera, J. Nishihira, and K. Iwabuchi Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways J Biol Chem 277 2002 7865 7874
29. H.Y. Lan, W. Mu, D.J. Nikolic-Paterson, and R.C. Atkins A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody cross-reactivity and retrieve antigens J Histochem Cytochem 43 1995 97 102
30. U. Arndt, G. Wennemuth, and P. Barth Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection J Virol 76 2002 9298 9306
31. P.K. Shah Role of inflammation and metalloproteinases in plaque disruption and thrombosis Vasc Med 3 1998 199 206
32. Y. Inokubo, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, and K. Okumura Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome Am Heart J 141 2001 211 217
33. C.M. Yu, C.P. Lau, K.W. Lai, X.R. Huang, W.H. Chen, and H.Y. Lan Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction Am J Cardiol 88 2001 774 777
34. J. Bernhagen, R.A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF) Biochemistry 33 1994 14144 14155
35. J. Orbe, L. Fernandez, and J.A. Rodriguez Different expression of MMPs/TIMP-1 in human atherosclerotic lesions Relation to plaque features and vascular bed Atherosclerosis 170 2003 269 276
36. M. Rouis, C. Adamy, and N. Duverger Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice Circulation 100 1999 533 540
37. E. Allaire, R. Forgough, and M. Clowes Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model J Clin Invest 102 1998 1413 1420
38. V. Lemaitre, P.D. Soloway, and J. D'Armiento Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1 Circulation 107 2003 333 338